Position in RVMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$104,201,093
+$47,730,255 QoQ
Shares Held
556,392
-4.2% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#60
of 685 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. RVMD ranks #2 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
This page
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in RVMD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,201,093 | 556,392 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $56,470,838 | 580,677 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $82,118,512 | 1,030,992 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $40,569,410 | 868,724 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $26,470,883 | 719,513 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $23,165,537 | 655,134 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,725,806 | 656,740 | Shares | Other | 2025-02-07 | |
| 2024-09-30 | $25,567,513 | 563,782 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,513,701 | 554,334 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $18,820,708 | 583,950 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $17,407,326 | 606,950 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,554,719 | 561,948 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $15,513,609 | 579,948 | Shares | Other | 2023-08-08 | |
| 2023-03-31 | $13,133,150 | 606,332 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $17,448,268 | 732,505 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,444,998 | 732,505 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $10,821,919 | 555,255 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $11,076,543 | 434,204 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,336,114 | 450,382 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $13,462,898 | 489,382 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $12,507,781 | 394,070 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $458 | 10 | Shares | Other | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||